RenovaCare
Business Services · Arizona, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9375 E Shea Blvd Ste 107A, Scottsdale, A...Phone Number
(888) 398-0202Website
www.renovacareinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RenovaCare
RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company's initial product under development targets the body's largest organ, the skin. The Company's flagship technology, the CellMist System, renders single-cell suspensions of tissue-specific pluripotent cells from donor tissues through sequential protease digestions. The RenovaCare CellMist System facilitates rapid healing of wounds or other afflicted tissues when applied topically as a gentle cell mist using the patented RenovaCare SkinGun. The Company's SkinGun is used to spray a liquid suspension of a patient's stem cells - the CellMist cell suspension - onto wounds. RenovaCare products are currently in development. They are not available for sale in the United States. There is no assurance that the Company's planned or filed submissions to the U.S. Food and Drug Administration will be accepted or cleared by the FDA.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RenovaCare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if RenovaCare had a recent Job posting/layoffs
Product Launch: Get notified when RenovaCare launches new products
Check if RenovaCare has recently received funding, and reach out quickly before it becomes old news!
RenovaCare, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if RenovaCare is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at RenovaCare
Funding: Get notified immidiatlly once RenovaCare has new funding data
Earning: See what the market has to say on RenovaCare recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to RenovaCare
Compare insights from companies similar to RenovaCare, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RenovaCare
<$5M
1-10
Private
-
1997
N/A
Company Profile Activity
Activity Insights
RenovaCare is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RenovaCare is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RenovaCare.
RenovaCare Tech Stack
A closer look at the technologies used by RenovaCare
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Lateral Move
Executive Move
Executive Move
Board of Directors
RenovaCare News & Media
Hagens Berman Sobol Shapiro LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of RenovaCare Securities - RCAR
NEWARK, N.J., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP announces that the United States District Court for the District of New Jersey has approved the following announcement of a proposed class action settlement that would benefit purchasers of RenovaCare, Inc. securities (OTC: RCAR):Lifshitz Law PLLC Announces Investigations of CorMedix Inc. (NASDAQGM: CRMD), FirstCash Holdings, Inc. (NASDAQ: FCFS), NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), Renovacare, Inc. (OTC-BB: RCAR)
NEW YORK, May 11, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQGM: CRMD)RenovaCare To Terminate StemCell Systems R&D Agreement
SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) — RenovaCare, a clinical-stage developer of patented technologies for isolating and spraying cells... Read More The post RenovaCare To Terminate StemCell Systems R&D Agreement appeared first on citybiz.RenovaCare Announces Termination of StemCell Systems R&D Agreement
SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced the termination of its July 1, 2020 Strategic Research and Development Agreement with StemCell Systems GmbH (SCS) and the closure of the RenovaCare R&D Innovation Center in Berlin, Germany. This decision ceases on-going development
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding RenovaCare
Sign Up For FreeTo access detailed company insights
RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company's initial product under development targets the body's largest organ, the skin. The Company's flagship technology, the CellMist System, renders single-cell suspensions of tissue-specific pluripotent cells fr... Read More
